Chronic kidney disease-associated pruritus (CKD-aP) is a condition that affects a significant number of people with advanced kidney disease, manifesting as persistent and often debilitating skin itchiness. Despite its prevalence, CKD-aP is frequently overlooked, leaving patients to suffer unnecessarily. Here’s a breakdown of CKD-aP’s causes, diagnosis, and treatment options, with actionable insights for managing this challenging condition.*

What is CKD-aP and Why Does It Matter?

CKD-aP, also known as uremic pruritus, is characterized by severe itchiness commonly experienced by patients with advanced chronic kidney disease (CKD) and end-stage kidney disease (ESKD). While it’s traditionally associated with uremia—the build-up of toxins due to impaired kidney function—recent research suggests a wider range of potential causes.

The relentless itching associated with CKD-aP significantly disrupts daily life, affecting:

• Sleep,  
• Mood, and 
• Adherence to dialysis schedules. 

In severe cases, scratching can lead to skin damage, infections, and emotional distress. 

Unpacking the Causes of CKD-aP

There are two leading theories about the cause of CKD-aP:

• Immune and inflammatory mechanisms. This theory suggests that CKD triggers an immune response that causes systemic inflammation and itching. Elevated inflammatory markers, such as low white blood cell counts, have been linked to CKD-aP.
• Imbalances in opioid receptors. This hypothesis focuses on an imbalance between the opioid receptor pathways in nerve cells that could result in heightened sensations of itching. 

Other CKD-related changes that may worsen CKD-aP include:

• Dry skin due to reduced sweat gland function
• Elevated levels of parathyroid hormone, calcium, and phosphorus
• Nerve damage from waste product buildup and electrolyte imbalances
• Toxin accumulation due to insufficient dialysis

Diagnosis and Treatment: What You Need to Know

CKD-aP is diagnosed through patient-reported symptoms, clinical evaluations, and the exclusion of other conditions such as liver disease or drug reactions. Symptoms may range from mild, intermittent itching to severe, persistent discomfort affecting the entire body.

Treatment strategies for CKD-aP include:

• Topical therapies. Emollients and analgesic creams can soothe the skin.
• Oral medications. Antihistamines are effective for mild cases, and nerve-pain medications like gabapentin or pregabalin often relieve severe itching.
• Phototherapy. Ultraviolet B (UVB) therapy can be used for non-transplant candidates, with precautions for photosensitive patients.
• FDA-approved drug. Difelikefalin administered during dialysis specifically addresses the nerve signal imbalances causing itching.
• Experimental treatments. Options like omega fatty acids and toxin-binding agents are under exploration.

Empowering Patients: Steps to Take

Managing CKD-aP begins with open communication.

• Report itching symptoms to your healthcare team.
• Ask about diagnostic tests and available treatments.
• Explore lifestyle adjustments and therapies to alleviate itching during dialysis.

When you advocate for yourself, you can access effective treatments to improve your comfort and overall well-being.

*National Kidney Foundation. (n.d.).Chronic Kidney Disease – Associated Pruritus (Itchy Skin). https://www.kidney.org/kidney-topics/chronic-kidney-disease-associated-pruritus-itchy-skin 

Responsum Health closely vets all sources to ensure that we always provide you with high-quality, reliable information. We do not, however, endorse or recommend any specific providers, treatments, or products, and the use of a given source does not imply an endorsement of any provider, treatment, medication, or procedure discussed within.